A5092763000- Antibiotic Use and Resistance
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Microbial infections and disease research
- Genomics and Phylogenetic Studies
- Bacteriophages and microbial interactions
- Inflammatory Biomarkers in Disease Prognosis
- Urinary Tract Infections Management
- Pneumonia and Respiratory Infections
- Long-Term Effects of COVID-19
- Multiple Sclerosis Research Studies
- Clinical Reasoning and Diagnostic Skills
- Vibrio bacteria research studies
- SARS-CoV-2 and COVID-19 Research
- Dermatological and COVID-19 studies
- Streptococcal Infections and Treatments
- COVID-19 Clinical Research Studies
Centre Hospitalier Universitaire Pointe-à-Pitre
2023-2024
Université Paris Cité
2023
Centre National de la Recherche Scientifique
2023
Institut Pasteur de la Guadeloupe
2023
Institut Pasteur
2023
Centre Hospitalier Universitaire de Nice
2023
Abstract Predicting how phages can selectively infect specific bacterial strains holds promise for developing novel approaches to combat infections and better understanding microbial ecology. Experimental studies on phage-bacteria interactions have been mostly focusing a few model organisms understand the molecular mechanisms which makes particular strain susceptible given phage. However, both bacteria are extremely diverse in natural contexts. How well concepts learned from well-established...
Abstract Background Despite cefoxitin's in vitro resistance to hydrolysis by extended-spectrum beta-lactamases (ESBL), treatment of ESBL-producing Klebsiella pneumoniae (KP) infections with cefoxitin remains controversial. The aim our study was compare the clinical efficacy as definitive antibiotic therapy for patients ESBL-KP bacteremia intensive care unit, versus carbapenem therapy. Methods This retrospective included all monomicrobial hospitalized unit between January 2013 and 2023 at...
Abstract Background Despite cefoxitin's in vitro resistance to hydrolysis by extended-spectrum beta-lactamases (ESBL), treatment of ESBL-producing Klebsiella pneumoniae (KP) infections with cefoxitin remains controversial. The aim our study was compare the clinical efficacy as definitive antibiotic therapy for patients ESBL-KP bacteremia intensive care unit, versus carbapenem therapy. Methods This retrospective included all monomicrobial hospitalized unit between January 2013 and 2023 at...